<DOC>
	<DOCNO>NCT02883296</DOCNO>
	<brief_summary>Main purpose study : - Analysis relapse risk anal fistulae prospective follow-up patient undergo pelvic MRI every 6 month one year . This monitoring also determine presence path fistula visible MRI inclusion visit associate increase risk perianal abscess infliximab adalimumab treatment . - Evaluation interest new magnetic resonance imaging sequence detection persistent anal fistula infliximab adalimumab treatment . Secondary purpose : - Description patient one paths fistula visible MRI least one year treatment infliximab adalimumab administer anal fistula show complete heal fistulae clinical examination inclusion visit . - Identification predictive factor ( include presence path fistulae visible MRI inclusion visit ) relapse anal fistulae 1-year-follow-up inclusion visit .</brief_summary>
	<brief_title>Long-term Follow-up Anal Fistulae Crohn 's Disease Treated With Anti-TNFalpha Interest New MRI Sequences</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<criteria>Aware cooperative , give write consent Crohn 's disease diagnose clinical , biological , endoscopic and/or radiologic criterion Patient treat infliximab adalimumab perianal fistulizing Crohn 's disease since least one year Absence drainage seton inclusion Absence active perianal lesion inclusion : absence suggestive symptom normal proctologic clinical examination without general anesthesia Patient MRI monitor perianal fistulizing Crohn 's disease Patient juridical protection without affiliation social security Refusal impossibility give informed consent Patient followedup MRI contraindication MRI , especially presence cardiac stimulators implantable defibrillator , cochlear implant , neurosurgical clip , intraorbital encephalic metallic foreign body , endoprostheses place since least 4 week osteosynthesis material place since less 6 week gadolinium intolerance history Surgery Crohn 's disease already plan inclusion visit , individual participate another study evaluate efficacy and/or tolerance medical surgical treatment perianal fistula Crohn 's disease Patient treat antiTNF luminal Crohn 's disease Patient active perineal lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>